Compare BPRN & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BPRN | PMI |
|---|---|---|
| Founded | 2007 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.3M | 202.7M |
| IPO Year | 2022 | N/A |
| Metric | BPRN | PMI |
|---|---|---|
| Price | $35.66 | $0.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.5K | ★ 1.7M |
| Earning Date | 04-23-2026 | 06-18-2026 |
| Dividend Yield | ★ 3.93% | N/A |
| EPS Growth | ★ 74.84 | N/A |
| EPS | ★ 2.71 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.96 | N/A |
| Revenue Next Year | $6.13 | N/A |
| P/E Ratio | $13.21 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.21 | $0.40 |
| 52 Week High | $37.99 | $13.68 |
| Indicator | BPRN | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 57.70 | 20.63 |
| Support Level | $35.54 | N/A |
| Resistance Level | $36.59 | $1.37 |
| Average True Range (ATR) | 0.69 | 0.10 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 74.93 | 6.77 |
Princeton Bancorp Inc is a full-service financial institution providing personal and business banking services, including checking and savings accounts, as well as a range of lending products such as residential, commercial, construction, and consumer loans, including home equity loans and lines of credit. The Bank operates branches and conducts loan origination activities in areas of the New York City metropolitan area. Its loan portfolio is segmented into commercial real estate (including owner-occupied, non-owner-occupied, and multi-family properties), construction loans (mainly for residential developments), commercial and industrial loans (for business purposes), residential real estate loans (secured by one-to-four family properties), and consumer/HELOC loans.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.